CTRI/2023/01/048957
Not yet recruiting
未知
Implementation and Evaluation of Medication Therapy Management in Patients with Hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ot applicable
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hypertensive patients with comorbidities and with polypharmacy (more than 5 drugs)
Exclusion Criteria
- •Patients with psychological illness or altered sensorium and those who are not willing to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study of the benefits of Medication Therapy Management in people with long term diseasesHealth Condition 1: I259- Chronic ischemic heart disease, unspecifiedHealth Condition 2: I10- Essential (primary) hypertensionHealth Condition 3: J453- Mild persistent asthmaHealth Condition 4: J41- Simple and mucopurulent chronic bronchitisHealth Condition 5: E118- Type 2 diabetes mellitus with unspecified complicationsCTRI/2022/02/040445Sapna K Dongre
Not yet recruiting
Phase 2
Clinical management of maantha sanni(Autism spectrum disorder)with maantha sanni thylam(Internal&External)Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skillsCTRI/2018/08/015287ATIONAL INSTITUTE OF SIDDHA
Not yet recruiting
Phase 2
Siddha Management for Maantha Sanni (Autism Spectrum Disorder) in ChildreHealth Condition 1: F840- Autistic disorderCTRI/2020/07/026285ational institute of siddha
Not yet recruiting
Not Applicable
Impact of Medication Therapy Management for Chronic Kidney Disease PatientsHealth Condition 1: N189- Chronic kidney disease, unspecifiedCTRI/2021/08/035807A
Recruiting
Not Applicable
on-interventional study on Therapeutic Drug Monitoring (TDM) in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection (ON-TARGET)C64Malignant neoplasm of kidney, except renal pelvisDRKS00025325Central European Society for Anticancer Drug Research (CESAR) e.V.80